| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/15/2004 | WO2004004687A2 Liposomal vaccine |
| 01/15/2004 | WO2004004686A2 Cartilage enhancing food supplements and methods of preparing the same |
| 01/15/2004 | WO2004004685A1 Medicinal suspension aerosol model systems |
| 01/15/2004 | WO2004004684A1 Controlled-release pharmaceutical formulations |
| 01/15/2004 | WO2004004683A1 Solid dispersions comprising two different polymer matrixes |
| 01/15/2004 | WO2004004682A2 Stable oily suspension of microgranules |
| 01/15/2004 | WO2004004681A1 Combination therapy and means for carrying out said therapy |
| 01/15/2004 | WO2004004654A2 Vaccines to induce mucosal immunity |
| 01/15/2004 | WO2004004639A2 A novel stable formulation |
| 01/15/2004 | WO2004004635A2 Radiolabeled compounds and liposomes and their methods of making and using the same |
| 01/15/2004 | WO2004004479A1 Compressed chewing gum |
| 01/15/2004 | WO2004004456A1 Antimicrobial concentrates |
| 01/15/2004 | WO2003090722A3 Microparticle pharmaceutical compositions for intratumoral delivery |
| 01/15/2004 | WO2003084936A8 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| 01/15/2004 | WO2003077943A3 Method for the production of a pharmaceutical preparation by adsorption in a poorly soluble aluminum compound |
| 01/15/2004 | WO2003072021A3 Oral pediatric trimethobenzamide formulations and methods |
| 01/15/2004 | WO2003070905A3 Electroporation methods for introducing bioactive agents into cells |
| 01/15/2004 | WO2003068936A3 Inhibition of lung metastases by aerosol delivery of p53 gene and anti-cancer compounds |
| 01/15/2004 | WO2003066073A3 Compositions containing oat straw and willowherb extract |
| 01/15/2004 | WO2003063820A3 Demixing-stable granulate |
| 01/15/2004 | WO2003063786A3 Methods and composition for delivering nucleic acids and/or proteins to the respiratory system |
| 01/15/2004 | WO2003059274A3 Vitamin formulation for cardiovascular health |
| 01/15/2004 | WO2003057170A8 Oral insulin therapy |
| 01/15/2004 | WO2003055590A8 Switchable surfaces |
| 01/15/2004 | WO2003053401A3 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 01/15/2004 | WO2003053350A3 Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability |
| 01/15/2004 | WO2003051332A8 Ophthalmic compositions comprising two different polyanionic components for lubricating eyes and methods for making and using same |
| 01/15/2004 | WO2003049689A3 Isoflavone composition for oral delivery |
| 01/15/2004 | WO2003045307A3 Pharmaceutical formulations comprising indolinone derivatives |
| 01/15/2004 | WO2003004620A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/15/2004 | WO2002072010A3 Taxane prodrugs |
| 01/15/2004 | US20040010306 A gradual removal of injured and diseased tissue providing a multilayer form of treatment such as regeneration or preventing proliferation of body tissue; biodegradable; stents; patches |
| 01/15/2004 | US20040010224 Drug delivery by in situ formation of an implant or particles in the body after exposure of a carrier phase to physiological conditions or environment; kit containing separately solvent for the carrier (polymer); sustained release |
| 01/15/2004 | US20040010215 Silver-containing compositions, devices and methods for making |
| 01/15/2004 | US20040010078 W/O/W composite emulsion |
| 01/15/2004 | US20040010060 Multilayer block polymer |
| 01/15/2004 | US20040010054 Pressure sensitive adhesives; acrylated resins; transdermal administering |
| 01/15/2004 | US20040010048 Resorbable structure for treating and healing of tissue defects |
| 01/15/2004 | US20040010046 Cleaning compound, dentifrices; reducing microorganisms |
| 01/15/2004 | US20040010003 9,9-dimethyl-3-oxa-9-azoniumtricyclo(3.3.1.0(2,4))nonanyl 2,2-diphenylpropionate quaternary salt |
| 01/15/2004 | US20040010000 Methods and dosage forms for controlled delivery of oxycodone |
| 01/15/2004 | US20040009971 Use of alprazolam in treatment of disorders of the central nervous system |
| 01/15/2004 | US20040009963 Use of salmeterol and fluticasone propionate combination |
| 01/15/2004 | US20040009961 Composition and therapies for hyperlipidaemia-associated disorders |
| 01/15/2004 | US20040009941 Microspheres and adjuvants for DNA vaccine delivery |
| 01/15/2004 | US20040009912 Method for treating schizoprhenia and related phychoes, and the use of erythropoietin or erythropoietin derivatives for treating schizophrenic disorders and related pyschoes |
| 01/15/2004 | US20040009897 Stabilized synthetic immunogen delivery system |
| 01/15/2004 | US20040009893 Ophthalmic lubricating solution adapted for use in lasik surgery |
| 01/15/2004 | US20040009875 Use of clear BSP film which is considerably thicker than coated films of prior art photo paper as the photoreceptive layer on top of a white substrate provides improved color, clarity, and depth to photos printed by dye sublimation |
| 01/15/2004 | US20040009248 Method for improving the cell protection |
| 01/15/2004 | US20040009235 Hydroxyapatite with specified particle size and a pharmaceutical carrier; osteoporosis; calcium deficiency |
| 01/15/2004 | US20040009233 Shark meat extract |
| 01/15/2004 | US20040009232 Dispersion of a liposoluble substance in water in the presence of a surfactant, adding a water soluble polyhydroxylated solid excipient such as mannitol, and granulating; drug delivery of megestrol acetate; excellent water dispersibility |
| 01/15/2004 | US20040009231 hGH (human growth hormone) formulations for pulmonary administration |
| 01/15/2004 | US20040009229 Stabilized nanoparticle formulations of camptotheca derivatives |
| 01/15/2004 | US20040009228 Bioabsorbable drug delivery system for local treatment and prevention of infections |
| 01/15/2004 | US20040009226 Injectable system for controlled drug delivery |
| 01/15/2004 | US20040009225 Contains at least 2 lipidic excipients, one of them being an hydrophilic excipient (having a high HLB value) and the other an oily excipient; stearoyl macroglyceride and soyabean oil for example |
| 01/15/2004 | US20040009223 Matrix-forming agent, a bioadhesive, a buffer, and water; for use in the vagina; forms a semisolid matrix on contact with semen and causes hardening of cervical mucus; for STD (sexually transmitted disease) prevention and contraception |
| 01/15/2004 | US20040009222 Processes for forming a drug delivery device |
| 01/15/2004 | US20040009221 Particularly ketorolac; pain treatment; core, a drug layer (which comprises the drug, a binder, and a disintegrant), a protecting layer, and an enteric coating |
| 01/15/2004 | US20040009220 Filler and a release controlling biopolymer such as hydroxypropyl methyl cellulose prepared by a granulation process yielding a quasi-monolithic compact which has a specified erosion time in gastric fluid |
| 01/15/2004 | US20040009219 Novel controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum |
| 01/15/2004 | US20040009218 Biodegradable articles obtained from enzymatically synthesized amylose |
| 01/15/2004 | US20040009217 Therapeutic liposome composition and method |
| 01/15/2004 | US20040009216 Administering liposomes comprising phospholipids and an aqueous layer, said liposomes having specified average diameter; treating various cardiovascular disorders, reducing cholesterol |
| 01/15/2004 | US20040009215 Skin friendly active substance patch for transdermal administration of hyperemic active substances |
| 01/15/2004 | US20040009214 An antianxiety agent such as buspirone; a dermal penetration enhancer of given formula such as octyl salicylate; and a volatile liquid such as ethanol |
| 01/15/2004 | US20040009213 Water-based delivery systems |
| 01/15/2004 | US20040009212 .2-.5% of a mucoadhesive polymer of carboxylvinylpolyester (i.e. carbopol or carbomer) and celluloses, 15%-40% of a thermoresponsive polymer having two critical points and a balance of water |
| 01/15/2004 | US20040009211 Flexible active substance-containing film or sheet which upon contact with water forms a spreadable solution, dispersion or emulsion on the skin |
| 01/15/2004 | US20040009205 Covalently crosslinked hydrogel having < equilibrium level of hydration for undergoing a volumetric expansion of >/= 50% and having a shape to occlude a lumen or void upon swelling |
| 01/15/2004 | US20040009181 Administering to a vertebrate inflicted with the condition a therapeutically effective amount of a peptide which is derived from alpha-melanocyte-stimulating hormone and biologically functional equivalents thereof |
| 01/15/2004 | US20040009180 Transdermal botulinum toxin compositions |
| 01/15/2004 | US20040009168 Multidose antibody formulation |
| 01/15/2004 | US20040009155 Method for sustaining direct cell delivery |
| 01/15/2004 | US20040009135 Hair growth formulation |
| 01/15/2004 | US20040009128 Heating a coating, which includes an amine drug salt on a substrate to a temperature sufficient to volatilize the amine drug from the coating by heating, forming an amine drug vapor, drawing air, condensing vapor to form aerosol particles |
| 01/15/2004 | US20040009127 Pulmonary administration of medicaments by means of dry powder inhalers; anti-asthmatics are widely used in the treatment of reversible airway obstruction, inflammation and hyperresponsiveness |
| 01/15/2004 | US20040009126 Inhalation system for prevention and treatment of intracellular infections |
| 01/15/2004 | US20040009125 First series of intranasal administration of E-selectin over period of two weeks, followed by a booster administration of E-selectin after at least two weeks from the first administration of E-selectin to minimize brain tissue damage |
| 01/15/2004 | US20040008570 Mixing apparatus |
| 01/15/2004 | DE10230588A1 Verfahren zur Herstellung von Brausetabletten Process for the preparation of effervescent tablets |
| 01/15/2004 | DE10228837A1 Hautkosmetische Zusammensetzung und Verwendung der Zusammensetzung als Hautbräunungsmittel Skin cosmetic composition and use of the composition as a tanning agent |
| 01/15/2004 | DE10228049A1 Flüssige Zubereitung enthaltend Oligopeptide The liquid formulation containing oligopeptides |
| 01/15/2004 | DE10227938A1 Pharmazeutische Zubereitung, Verfahren zu ihrer Herstellung sowie deren Verwendung A pharmaceutical preparation, processes for their preparation and their use |
| 01/15/2004 | DE10227935A1 Antibiotische Beschichtung von porösen Körpern und Verfahren zu ihrer Herstellung sowie Verwendung The antibiotic coating of porous bodies and processes for their preparation and use |
| 01/15/2004 | DE10227914A1 Pharmazeutische Zubereitung mit retardierender Wirkstofffreisetzung, Verfahren zu ihrer Herstellung und Verwendung Pharmaceutical formulation having retarded active substance release, methods for their preparation and use |
| 01/15/2004 | DE10227232A1 Saure Insulinzubereitungen mit verbesserter Stabilität Acidic insulin preparations with improved stability |
| 01/15/2004 | CA2531280A1 Vaccines to induce mucosal immunity |
| 01/15/2004 | CA2494508A1 Nucleic acid compositions for stimulating immune responses |
| 01/15/2004 | CA2492037A1 Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase |
| 01/15/2004 | CA2492033A1 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 01/15/2004 | CA2492026A1 New pharmaceutical compositions based on new anticholinergics and pde-iv inhibitors |
| 01/15/2004 | CA2491724A1 Ciclesonide-containing sterile aqueous suspension |
| 01/15/2004 | CA2491685A1 Liquid formulations with high concentration of human growth hormone (hgh) comprising 1,2-prolpylene glycol |
| 01/15/2004 | CA2491682A1 Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 01/15/2004 | CA2491673A1 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |
| 01/15/2004 | CA2491484A1 Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 01/15/2004 | CA2491478A1 Liquid formulations with high concentration of human growth hormone (hgh) comprising phenol |